Piper Sandler Maintains Neutral on Edwards Lifesciences, Lowers Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Maeder has maintained a Neutral rating on Edwards Lifesciences (NYSE:EW) and lowered the price target from $83 to $68.
October 26, 2023 | 4:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained a Neutral rating on Edwards Lifesciences and lowered the price target from $83 to $68.
The lowering of the price target by Piper Sandler indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Edwards Lifesciences' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100